×

:

Not a valid Time
This is a required field.
Walking London's Medical History Second Edition

Walking London's Medical History Second Edition

EMQs in Surgery 2E

EMQs in Surgery 2E

Heparin-Induced Thrombocytopenia, Fifth Edition

Regular Price $357.01 Special Price $321.30 $292.09
Stock Status: 4-6 weeks delivery
Availability: In stock
SKU
9781841848600
 

Although first reported in 1973, immune heparin-induced thrombocytopenia (HIT) remains one of the most frequent and devastating adverse drug reactions encountered by physicians. This thoroughly updated fifth edition from international experts Professors Warkentin and Greinacher is the gold standard for accurate diagnosis and management of this condition. Identifying key signs and symptoms and providing clear intervention strategies—including the use of alternative anticoagulants to manage critical circumstances—this is an essential resource for all clinicians and a "must" for hematology consultants.

Heparin-Induced Thrombocytopenia, Fifth Edition

explores:
More Information
Author Theodore E. Warkentin, Andreas Greinacher
Table Of Content

History of Heparin-Induced Thrombocytopenia
Theodore E. Warkentin
Clinical Picture of Heparin-Induced Thrombocytopenia
Theodore E. Warkentin
Differential Diagnosis of Heparin-Induced Thrombocytopenia and Scoring Systems
Theodore E. Warkentin, Adam Cuker, MD, MS
Frequency of Heparin-Induced Thrombocytopenia
Lori-Ann Linkins, David H. Lee
Nonimmune Heparin-Platelet Interactions: Implications for the Pathogenesis of Heparin-Induced Thrombocytopenia
McDonald K. Horne III, Andreas Greinacher
Role of Heparin-Dependent Antigens in Immune Heparin-Induced Thrombocytopenia
Jean Amiral, Anne Marie Vissac
Role of Sulfated Polysaccharides and other Polyanions in the Pathogenesis of Heparin-Induced Thrombocytopenia
Susanne Alban, Krystin Krauel, Andreas Greinacher
Platelet and Leukocyte Fcγ Receptors in Heparin-Induced Thrombocytopenia
Gregory A. Denomme
Cellular and Molecular Immunopathogenesis of Heparin-Induced Thrombocytopenia
Lubica Rauova, Gowthami M. Arepally
Murine Models of Heparin-Induced Thrombocytopenia
Gowthami M. Arepally, Bruce S. Sachais, Douglas B. Cines, Mortimer Poncz, Lubica Rauova, Steven E. McKenzie
Laboratory Testing for Heparin-Induced Thrombocytopenia
Theodore E. Warkentin, Andreas Greinacher
Treatment of Heparin-Induced Thrombocytopenia: An Overview
Andreas Greinacher, Theodore E. Warkentin
Argatroban Therapy in Heparin-Induced Thrombocytopenia
Lawrence Rice, Martin Beiderlinden, Marcie J. Hursting
Recombinant Hirudin for the Treatment of Heparin-Induced Thrombocytopenia
Andreas Greinacher
Bivalirudin for the treatment of Heparin-Induced Thrombocytopenia
John R. Bartholomew, Jayne Prats, PhD.
Danaparoid for the Treatment of Heparin-Induced Thrombocytopenia
Beng Hock Chong, Harry N. Magnani
Fondaparinux and Other Emerging Anticoagulants to Treat Heparin-Induced Thrombocytopenia
Theodore E. Warkentin, John W. Eikelboom
Hemodialysis in HIT
Karl-Georg Fischer
Management of Intraoperative Anticoagulation in Patients with Heparin-Induced Thrombocytopenia Undergoing Cardiovascular Surgery
Sixten Selleng, Andreas Koster
Heparin-Coated Intravascular Devices and Heparin-Induced Thrombocytopenia
Theodore E. Warkentin
Heparin-Induced Thrombocytopenia in Children
Anne F. Klenner, Andreas Greinacher
A Clinician’s Perspective on Heparin-Induced Thrombocytopenia: Paradoxes, Myths, and Continuing Challenges
Lawrence Rice

Publish Date 26 Oct 2012
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account